Bedriye Büşra Demirel

Bedriye Büşra Demirel

Auto-generated profile, based on publicly available information

Bedriye Büşra Demirel

Department of Nuclear Medicine, Ankara Oncology Research and Training Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2013 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
BABurcu Esen Akkas
Burcu Esen Akkas
BDBusra Bedriye Demirel
Busra Bedriye Demirel
ADAysen Dizman
Aysen Dizman
GVGulin Ucmak Vural
Gulin Ucmak Vural

30 March 2013 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
BDBusra B. Demirel
Busra B. Demirel
BABurcu Esen Akkas
Burcu Esen Akkas
GVGulin Ucmak Vural
Gulin Ucmak Vural
Clinical Factors Related with Helicobacter Pylori Infection - Is there an Association with Gastric Cancer History in First-Degree Family Members? Helicobacter pylori;gastric cancer;C-14 urea breath test; Background: The aim of this study was to assess clinical factors associated with Helicobacter pylori positivity and to evaluate the incidence of gastric carcinoma in first-degree family members of infected patients. A total of 580 patients (mean age:$38{\pm}17$) with gastrointestinal complaints underwent C-14 urea breath test (UBT). Patients were grouped as: Group-1, untreated patients (n:384); and Group-2, patients who previously treated with eradication triple therapy (n:196). C-14 UBT was performed 1-2 months after the completion of eradication therapy. Associations of H pylori positivity with age, gender, ABO and Rhesus groups, smoking, dietary habits, and history of gastric cancer in first-degree family members were evaluated. The frequency of H pylori positivity was significantly higher in group-1 (58%) compared to group-2 (20%), p=0.001. There were no correlations between H pylori positivity and age, gender, ABO groups, Rhesus subgroups, smoking and dietary habits in both patient groups. The frequency of gastric cancer in family members was significantly higher in patients with H pylori infection among group-1, compared to infected patients among group-2 (56% vs. 28.6% respectively, p=0.03). We observed a significant association between H pylori positivity and the presence of gastric cancer in first-degree relatives of group-1 patients. Our results provide some confirmation of the presence of a link between gastric cancer development and H pylori. C-14 UBT is a sensitive, reliable and a widely recommended test for the detection of H pylori infection and recurrence. We suggest that detection and eradication of H pylori may contribute to a reduced risk of gastric cancer in the family members of infected patients.

28 June 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
AFAykut Kürşat Fi̇dAn
Aykut Kürşat Fi̇dAn
GUGülin Uçmak
Gülin Uçmak
BDBedriye Büşra Demi̇rEl
Bedriye Büşra Demi̇rEl
HEHulya Efeturk
Hulya Efeturk
IÖİpEk Öztürk
İpEk Öztürk
IIİnCi Ergürhan İlHan
İnCi Ergürhan İlHan
The aim of this study was to investigate the contribution of fluorine-18 (F-18) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging in staging of pediatric osteosarcoma patients and also to evaluate the ability of metabolic parameters from the primary tumor to predict tumor necrosis rate (TNR). F-18 FDG-PET/CT imaging was performed in staging 37 pediatric osteosarcoma patients. The metabolic parameters SUVmax (maximum standardised uptake value), MTV (metabolic tumour volume) and TLG (total lesion glycolysis) were measured from the primary tumor. TNR level of the primary tumor was histopathologically measured after standard neoadjuvant chemotherapy treatment. The contribution of F-18 FDG-PET/CT to staging of pediatric osteosarcoma patients and the accuracy of metabolic parameters of the primary tumor to predict TNR were analized by regression analysis. MTV and TLG of the primary tumor were found to efficiently predict histopathologic TNR, whereas SUVmax was not (p=0.012, p=0.027, p=0.25, respectively). Also 5 of 12 patients (41.6%) who were initially defined as localised osteosarcoma were upstaged in consequence of staging F-18 FDG-PET/CT findings. F-18 FDG-PET/CT staging in pediatric osteosarcoma patients can effectively distinguish metastatic-localised disease. MTV and TLG values are important parameters which can efficiently be used to predict TNR.

2 August 2024 in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Verified
Journal Article
Closed access
SASeda Gülbahar Ateş
Seda Gülbahar Ateş
BDBedriye Büşra Demirel
Bedriye Büşra Demirel
EKEsra Kekilli
Esra Kekilli
EÖErdem Öztürk
Erdem Öztürk
GUGülin Uçmak
Gülin Uçmak

23 February 2024 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
SASeda Gülbahar Ateş
Seda Gülbahar Ateş
BDBedriye Büşra Demirel
Bedriye Büşra Demirel
HBHalil Basar
Halil Basar
GUGülin Uçmak
Gülin Uçmak
Objectives: This retrospective study aimed to evaluate the prognostic importance of F-18-fluorodeoxyglucose (F-18-FDG)-positive pelvic lymph nodes (LNs) and extra -pelvic disease on staging F-18-FDG positron emission tomography/computed tomography (PET/CT) in patients with bladder cancer. Methods: Bladder cancer patients who underwent staging F-18-FDG PET/CT were included in the study. Histopathologic features of tumors, therapy histories, presence of distinguishable tumors on CT and PET images, sizes and maximum standardized uptake value (SUVmax) of primary tumors, total numbers, sizes, and SUVmax of F-18-FDG-positive pelvic and extra -pelvic LNs, and total numbers and SUVmax of distant metastases (M1a/1b) were recorded. Patients were followed up until death or the last medical visit. Factors predicting overall survival were determined using Cox regression analysis. Results: Fifty-five patients [median age: 70 (53-84), 48 (87.3%) male, 7 (12.7%) female] with bladder cancer were included in this study. Twentynine (52.7%) patients had 18F-FDG positive pelvic LNs, while 24 (43.7%) patients had 18F-FDG positive extra -pelvic disease. Patients with F-18-FDG- positive pelvic LNs had a higher rate of extra -pelvic disease (p=0.003). The median follow-up duration was 13.5 months. The median overall survival was 16.3 months [95% confidence interval (CI) 8.9-23.7]. The primary tumor distinguishability on PET (p=0.011) and CT (p=0.009) images, the presence of F-18-FDG-positive pelvic LNs (p<0.001) and F-18-FDG-positive extra -pelvic disease/distant metastases (M1a/M1b) (p<0.001), and the number of distant metastases (p=0.034) were associated with mortality. The F-18-FDG-positive extra -pelvic disease/distant metastases [p=0.029, odds ratio: 4.15 (95% CI 1.16-14.86)] was found to be an independent predictor of mortality in patients with bladder cancer. Conclusion: The presence of 18F-FDG-positive extra -pelvic disease in pretreatment 18F-FDG PET/CT is an important prognostic factor in bladder cancer patients.

21 October 2015 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
BABurcu Esen Akkas
Burcu Esen Akkas
BDBusra Bedriye Demirel
Busra Bedriye Demirel
EUElif Nisa Unlu
Elif Nisa Unlu
GUGulin Ucmak
Gulin Ucmak
Osteitis fibrosa cystica is a skeletal disorder seen in advanced stages of persistent hyperparathyroidism. Although the measurement of serum Ca and intact-parathormone levels provides early diagnosis and decreases the incidence of radiographic bone involvement, progressive major bone lesions may still be seen in developing countries even in the modern era. We aimed to share, by writing up this report, our astonishment after observing how the skeletal system can be ruined by persistent hyperparathyroidism.